Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

The Walter and Eliza Hall Institute of Medical Research

2 abstracts

Abstract
Olaparib in HR-deficient (HRD), metastatic triple-negative breast cancer (TNBC) and relapsed ovarian cancer (ROC) without germline mutations in BRCA1 or BRCA2: Phase 2 EMBRACE trial.
Org: NHMRC Clinical Trials Centre, The University of Sydney, St George Hospital, The University of Melbourne, Royal North Shore Hospital, Sydney, Australia,
Abstract
Awareness, preferences, and experiences of thrombosis and thromboprophylaxis in adults commencing systemic anticancer therapies: TARGET-TP trial.
Org: Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Bendigo Cancer Centre, Bendigo Health, Bendigo, VIC, Australia,